{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:46:05Z","timestamp":1784007965481,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatic arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia (HHT) patients are most commonly hepatic artery to hepatic venous shunts which can result in high-output heart failure. This condition can be debilitating and is a leading cause of liver transplantation in HHT patients. However, it is not known what characteristics can discriminate between asymptomatic patients and those who will develop heart failure symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>176 patients with HHT were evaluated with computed tomography angiography (CTA) between April 2004 and February 2019 at our HHT Center of Excellence. 63\/176 (35.8%) patients were found to have hepatic AVMs on CTA. 18 of these patients were excluded because of the presence of another condition which could confound evaluation of heart failure symptoms. In the remaining 45 patients included in our cohort, 25\/45 (55.6%) patients were classified as asymptomatic and 20\/45 (44.4%) were classified as symptomatic, and these groups were compared.<\/jats:p>\n                    <jats:p>In symptomatic patients, mean common hepatic artery (CHA) diameter was significantly higher (11.1 versus 8.4\u00a0mm) and mean hemoglobin levels were significantly lower (10.7 vs 12.6\u00a0g\/dL). A stepwise multiple logistic regression analysis demonstrated that both CHA diameter and hemoglobin level were independent predictors of heart failure symptoms with ORs of 2.554 (95% CI 1.372\u20134.754) and 0.489 (95% CI 0.299\u20130.799), respectively. The receiver operator characteristic (ROC) curve of our analysis demonstrated an AUC of 0.906 (95% CI 0.816\u20130.996), sensitivity 80.0% (95% CI 55.7\u201393.4%), and specificity 75.0% (95% CI 52.9\u201389.4%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CTA is an effective and easily reproducible method to evaluate hepatic involvement of HHT. Utilizing CTA, clinical, and laboratory data we determined CHA diameter and hemoglobin level were independent predictors of heart failure symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-021-02109-4","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T07:03:12Z","timestamp":1637218992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9710-8488","authenticated-orcid":false,"given":"Lucas R.","family":"Cusumano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Tesoriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig B.","family":"Wilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sayre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Quirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin P.","family":"McWilliams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"2109_CR1","doi-asserted-by":"crossref","unstructured":"Garg N, Khunger M, Gupta A, Kumar N. Optimal management of hereditary hemorrhagic telangiectasia. J Blood Med. 2014;191\u2013206.","DOI":"10.2147\/JBM.S45295"},{"issue":"5","key":"2109_CR2","first-page":"363","volume":"79","author":"PJ Reilly","year":"1984","unstructured":"Reilly PJ, Nostrant TT. Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol. 1984;79(5):363\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"2109_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/1096-8628(20000814)93:4<320::AID-AJMG12>3.0.CO;2-R","volume":"93","author":"JE McDonald","year":"2000","unstructured":"McDonald JE, Miller FJ, Hallam SE, Nelson L, Marchuk DA, Ward KJ. Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. Am J Med Genet. 2000;93(4):320\u20137.","journal-title":"Am J Med Genet"},{"issue":"1","key":"2109_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91(1):66\u20137.","journal-title":"Am J Med Genet"},{"issue":"1","key":"2109_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1148\/radiol.2301021745","volume":"230","author":"AA Ianora","year":"2004","unstructured":"Ianora AA, Memeo M, Sabba C, Cirulli A, Rotondo A, Angelelli G. Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement. Radiology. 2004;230(1):250\u20139.","journal-title":"Radiology"},{"issue":"2","key":"2109_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/0016-5085(93)90723-P","volume":"105","author":"G Bernard","year":"1993","unstructured":"Bernard G, Mion F, Henry L, Plauchu H, Paliard P. Hepatic involvement in hereditary hemorrhagic telangiectasia: clinical, radiological, and hemodynamic studies of 11 cases. Gastroenterology. 1993;105(2):482\u20137.","journal-title":"Gastroenterology"},{"issue":"9","key":"2109_CR7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/j.1572-0241.1998.00486.x","volume":"93","author":"JF Trotter","year":"1998","unstructured":"Trotter JF, Suhocki PV, Lina JR, Martin LW, Parrish JL, Swantkowski T. Hereditary hemorrhagic telangiectasia causing high output cardiac failure: treatment with transcatheter embolization. Am J Gastroenterol. 1998;93(9):1569\u201371.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"2109_CR8","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/01.sla.0000247258.35406.a4","volume":"244","author":"J Lerut","year":"2006","unstructured":"Lerut J, Orlando G, Adam R, Sabb\u00e0 C, Pfitzmann R, Klempnauer J, et al. Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry. Ann Surg. 2006;244(6):854\u201362 (discussion 62\u20134).","journal-title":"Ann Surg"},{"issue":"3","key":"2109_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jhep.2006.12.008","volume":"46","author":"G Garcia-Tsao","year":"2007","unstructured":"Garcia-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia (HHT). J Hepatol. 2007;46(3):499\u2013507.","journal-title":"J Hepatol"},{"issue":"7","key":"2109_CR10","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1007\/s10620-011-1585-2","volume":"56","author":"E Buscarini","year":"2011","unstructured":"Buscarini E, Leandro G, Conte D, Danesino C, Daina E, Manfredi G, et al. Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia. Dig Dis Sci. 2011;56(7):2166\u201378.","journal-title":"Dig Dis Sci"},{"issue":"13","key":"2109_CR11","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJM200009283431305","volume":"343","author":"G Garcia-Tsao","year":"2000","unstructured":"Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2000;343(13):931\u20136.","journal-title":"N Engl J Med"},{"key":"2109_CR12","unstructured":"Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Annals of Internal Medicine. 2020;173(12):989\u20131001."},{"issue":"4","key":"2109_CR13","doi-asserted-by":"publisher","first-page":"W399","DOI":"10.2214\/AJR.05.1068","volume":"187","author":"JS Wu","year":"2006","unstructured":"Wu JS, Saluja S, Garcia-Tsao G, Chong A, Henderson KJ, White RI. Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients. Am J Roentgenol. 2006;187(4):W399\u2013405.","journal-title":"Am J Roentgenol"},{"key":"2109_CR14","unstructured":"Dolgin M, New York Heart A, Criteria C. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. Boston: Little, Brown; 1994."},{"issue":"3","key":"2109_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1378\/chest.12-0924","volume":"144","author":"R Cartin-Ceba","year":"2013","unstructured":"Cartin-Ceba R, Swanson KL, Krowka MJ. Pulmonary arteriovenous malformations. Chest. 2013;144(3):1033\u201344.","journal-title":"Chest"},{"issue":"1","key":"2109_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00270-019-02328-0","volume":"43","author":"LR Cusumano","year":"2020","unstructured":"Cusumano LR, Duckwiler GR, Roberts DG, McWilliams JP. Treatment of recurrent pulmonary arteriovenous malformations: comparison of proximal versus distal embolization technique. Cardiovasc Intervent Radiol. 2020;43(1):29\u201336.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"2109_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1164\/ajrccm.158.2.9711041","volume":"158","author":"JR Gossage","year":"1998","unstructured":"Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med. 1998;158(2):643\u201361.","journal-title":"Am J Respir Crit Care Med"},{"issue":"49","key":"2109_CR18","first-page":"834","volume":"113","author":"D Berliner","year":"2016","unstructured":"Berliner D, Schneider N, Welte T, Bauersachs J. The differential diagnosis of dyspnea. Dtsch Arztebl Int. 2016;113(49):834\u201345.","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"2109_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/01.CIR.8.1.111","volume":"8","author":"WB Porter","year":"1953","unstructured":"Porter WB, James GW. The heart in anemia. Circulation. 1953;8(1):111\u20136.","journal-title":"Circulation"},{"issue":"9","key":"2109_CR20","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1249\/01.MSS.0000084533.75912.B4","volume":"35","author":"WW Storms","year":"2003","unstructured":"Storms WW. Review of exercise-induced asthma. Med Sci Sports Exerc. 2003;35(9):1464\u201370.","journal-title":"Med Sci Sports Exerc"},{"issue":"suppl 1","key":"2109_CR21","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1093\/cid\/ciq012","volume":"52","author":"SS Shrestha","year":"2011","unstructured":"Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009\u2013April 2010). Clin Infect Dis. 2011;52(suppl 1):S75\u201382.","journal-title":"Clin Infect Dis"},{"key":"2109_CR22","first-page":"203794","volume":"2012","author":"SA Al-Busafi","year":"2012","unstructured":"Al-Busafi SA, McNabb-Baltar J, Farag A, Hilzenrat N. Clinical manifestations of portal hypertension. Int J Hepatol. 2012;2012:203794.","journal-title":"Int J Hepatol."},{"issue":"11","key":"2109_CR23","first-page":"1893","volume":"74","author":"J Doust","year":"2006","unstructured":"Doust J, Lehman R, Glasziou P. The role of BNP testing in heart failure. Am Fam Physician. 2006;74(11):1893\u20138.","journal-title":"Am Fam Physician"},{"issue":"2","key":"2109_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmg.2009.069013","volume":"48","author":"ME Faughnan","year":"2011","unstructured":"Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48(2):73\u201387.","journal-title":"J Med Genet"},{"issue":"4","key":"2109_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00270-008-9344-2","volume":"32","author":"M-F Carette","year":"2009","unstructured":"Carette M-F, Nedelcu C, Tassart M, Grange J-D, Wislez M, Khalil A. Imaging of hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol. 2009;32(4):745\u201357.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"2109_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1055\/s-2004-813549","volume":"25","author":"E Buscarini","year":"2004","unstructured":"Buscarini E, Danesino C, Olivieri C, Lupinacci G, De Grazia F, Reduzzi L, et al. Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia\u2014results of extensive screening. Ultraschall Med. 2004;25(5):348\u201355.","journal-title":"Ultraschall Med"},{"issue":"5","key":"2109_CR27","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1053\/jhep.2003.50197","volume":"37","author":"M Caselitz","year":"2003","unstructured":"Caselitz M, Bahr MJ, Bleck JS, Chavan A, Manns MP, Wagner S, et al. Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT). Hepatology. 2003;37(5):1139\u201346.","journal-title":"Hepatology"},{"issue":"2","key":"2109_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.7863\/jum.2002.21.2.187","volume":"21","author":"G Bodner","year":"2002","unstructured":"Bodner G, Peer S, Karner M, Perkmann R, Neuhauser B, Vogel W, et al. Nontumorous vascular malformations in the liver. J Ultrasound Med. 2002;21(2):187\u201397.","journal-title":"J Ultrasound Med"},{"issue":"1","key":"2109_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","volume":"138","author":"IS Anand","year":"2018","unstructured":"Anand IS, Gupta P. Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circulation. 2018;138(1):80\u201398.","journal-title":"Circulation"},{"issue":"3","key":"2109_CR30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1172\/JCI101610","volume":"24","author":"ES Brannon","year":"1945","unstructured":"Brannon ES, Merrill AJ, Warren JV, Stead EA. The cardiac output in patients with chronic anemia as measured by the technique of right atrial catherization. J Clin Invest. 1945;24(3):332\u20136.","journal-title":"J Clin Invest"},{"issue":"4","key":"2109_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.diii.2014.01.023","volume":"97","author":"A Cavel","year":"2016","unstructured":"Cavel A, Bleuzen A, Bertrand P, Patat F, Cottier JP. Comparison between Doppler ultrasonography and multiphase multidetector-row computed tomography in the detection of liver involvement in Rendu-Osler disease: an analysis of 62 patients. Diagn Interv Imaging. 2016;97(4):451\u20139.","journal-title":"Diagn Interv Imaging"},{"issue":"5","key":"2109_CR32","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/hep.22514","volume":"48","author":"R Gincul","year":"2008","unstructured":"Gincul R, Lesca G, Gelas-Dore B, Rollin N, Barthelet M, Dupuis-Girod S, et al. Evaluation of previously nonscreened hereditary hemorrhagic telangiectasia patients shows frequent liver involvement and early cardiac consequences. Hepatology. 2008;48(5):1570\u20136.","journal-title":"Hepatology"},{"issue":"1","key":"2109_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13023-018-0982-4","volume":"14","author":"E Buscarini","year":"2019","unstructured":"Buscarini E, Botella LM, Geisthoff U, Kjeldsen AD, Mager HJ, Pagella F, et al. Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2019;14(1):28.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2109_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/lt.21990","volume":"16","author":"S Dupuis-Girod","year":"2010","unstructured":"Dupuis-Girod S, Chesnais AL, Ginon I, Dumortier J, Saurin JC, Finet G, et al. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study. Liver Transpl. 2010;16(3):340\u20137.","journal-title":"Liver Transpl"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02109-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02109-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02109-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T07:10:53Z","timestamp":1637219453000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02109-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2109"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02109-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-824554\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for this retrospective study has been approved by the institutional review board and waived informed consent for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Justin P. McWilliams, wishes to disclose consultancy fees from Penumbra and Johnson & Johnson. We have no commercial affiliation or consultancy that could be construed as a conflict of interest with respect to the submitted data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"478"}}